Biohaven Pharmaceutical Holding Company Ltd.

Industry: Biopharmacy, Future technologies

Main business locations: Worldwide

Registered office:
C/O Maples Corporate Services (BVI) Limited
Kingston Chambers, Sea Meadow House
Road Town, Tortola
British Virgin Islands

Listed on: NYSE

About the BVI company:

Biohaven Pharmaceutical Holding is a company registered in the British Virgin Islands and listed on the New York Stock Exchange, focused on finding treatments for neurological diseases. It is a clinical-stage company with portfolio comprised of innovative, late-stage product candidates targeting neurological and neuropsychiatric diseases.

Biohaven combines internal development and research with intellectual property licensed from companies and institutions including Bristol-Myers Squibb Company, AstraZeneca AB, Yale University, Catalent, ALS Biopharma LLC and Massachusetts General Hospital. Biohaven had its first public offering in 2017. The company has multiple clinical trials across product candidates.